Merck Non Current Assets Total Over Time
| MRK Stock | USD 127.51 0.75 0.58% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Merck Performance and Merck Correlation. Merck |
Is Merck's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merck. If investors know Merck will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merck listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.685 | Dividend Share 2.96 | Earnings Share 0.91 | Revenue Per Share 24.215 | Quarterly Revenue Growth 0.089 |
The market value of Merck Company is measured differently than its book value, which is the value of Merck that is recorded on the company's balance sheet. Investors also form their own opinion of Merck's value that differs from its market value or its book value, called intrinsic value, which is Merck's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merck's market value can be influenced by many factors that don't directly affect Merck's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merck's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Current Assets Total Analysis
Compare Merck Company and related stocks such as Shuttle Pharmaceuticals, Lifecore Biomedical, and Journey Medical Corp Non Current Assets Total Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SHPH | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 202.9 K | 142 K | 75.2 K | 358.7 K | 214.2 K |
| LFCR | 1.1 M | 196.5 M | 205.3 M | 222.7 M | 253.3 M | 257 M | 276.7 M | 307.6 M | 386.1 M | 384.2 M | 354.6 M | 171.4 M | 171.4 M | 197.2 M | 160.7 M |
| DERM | 72.8 M | 72.8 M | 72.8 M | 72.8 M | 72.8 M | 4.7 M | 28.6 M | 4.2 M | 8.9 M | 8.6 M | 16.7 M | 12.8 M | 27.5 M | 20.4 M | 16.4 M |
| LSDI | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 18.3 K | 3.5 M | 2.7 M | 5 M | 5.7 M | 3.1 M |
| ORGO | 290.2 K | 290.2 K | 290.2 K | 290.2 K | 290.2 K | 290.2 K | 310 M | 312.5 M | 92.5 M | 95.1 M | 120.2 M | 216.3 M | 226.8 M | 235 M | 196.6 M |
| CYTH | 453.5 K | 2.5 M | 2.3 M | 2.2 M | 2.2 M | 2.2 M | 233 K | 192.9 K | 148.2 K | 155.2 K | 137.7 K | 84.5 K | 56.7 K | 929.3 K | 694.6 K |
| SXTC | 526.3 K | 526.3 K | 526.3 K | 526.3 K | 526.3 K | 526.3 K | 526.3 K | 1.6 M | 1.9 M | 2.1 M | 11.3 M | 11.1 M | 10 M | 11.5 M | 6 M |
Merck Company and related stocks such as Shuttle Pharmaceuticals, Lifecore Biomedical, and Journey Medical Corp Non Current Assets Total description
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Merck Company | MRK |
 | Giant ImpactFama & French Classification |
| Location | New Jersey; U.S.A |
| Exchange | New York Stock Exchange |
USD 127.51
Check out Merck Performance and Merck Correlation. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Merck Stock analysis
When running Merck's price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Merck technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.